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Dendritic cell (DC) populations consist of multiple
subsets that are essential orchestrators of the
immune system. Technological limitations have so
far prevented systems-wide accurate proteome
comparison of rare cell populations in vivo. Here,
we used high-resolution mass spectrometry-based
proteomics, combined with label-free quantitation
algorithms, to determine the proteome of mouse
splenic conventional and plasmacytoid DC subsets
to a depth of 5,780 and 6,664 proteins, respectively.
We found mutually exclusive expression of pattern
recognition pathways not previously known to be
different amongconventional DCsubsets.Our exper-
iments assigned key viral recognition functions to be
exclusively expressed in CD4+ and double-negative
DCs. The CD8a+ DCs largely lack the receptors
required to sense certain viruses in the cytoplasm.
By avoiding activation via cytoplasmic receptors,
including retinoic acid-inducible gene I, CD8a+ DCs
likely gain a window of opportunity to process and
present viral antigens before activation-induced
shutdown of antigen presentation pathways occurs.
INTRODUCTION
Dendritic cells (DCs) are involved in immune responses ranging
from resistance to infection to self-tolerance. Mouse spleen
contains two types of DCs, plasmacytoid DCs (pDCs) and
conventional DCs (cDCs). cDCs can be further segregated
according to expression of surface markers into CD4+ cDCs,
CD8a+ cDCs and CD4CD8a cDCs (double-negative [DN])
(Shortman and Naik, 2007; Vremec et al., 2000). Importantly,
different DC subsets have specialized roles in immuneresponses (Villadangos and Schnorrer, 2007; Villadangos and
Young, 2008). pDCs uniquely secrete very large amounts of
type I interferons (IFN I) directly upon activation and, therefore,
play an important role in response to viral infections (Fuchs-
berger et al., 2005). Among the cDC subsets, CD8a+ cDCs are
important in the presentation of antigen in the context of different
viral infections (Allan et al., 2003; Belz et al., 2004, 2005). CD8a+
cDCs cross-present antigens, a process in which exogenous
antigen is presented to T cells by MHC class I molecules to
activate cytotoxic CD8+ T cells (Heath et al., 2004), so presenta-
tion of viral antigen by CD8a+ cDCs does not necessarily require
direct infection. CD8a+ cDCs have been mainly associated with a
T helper 1 (Th1) cell-inducing profile due to their ability to secrete
extremely high amounts of the proinflammatory cytokine IL-12
(Maldonado-Lo´pez et al., 1999). CD4+ cDCs and DN cDCs are
potent in stimulating CD4+ T cells via MHC II-antigen complexes.
In contrast to CD8a+ cDCs, CD4+ and DN cDCs have been
mainly associated with stimulating a Th2 cell response (Maldo-
nado-Lo´pez et al., 1999).
Innate immunity largely depends on the recognition of highly
conserved structures of pathogens that are distinct from the
host, so-called pathogen-associated molecular patterns
(PAMPs) (Janeway and Medzhitov, 2002). PAMPs comprise
two broad classes of biochemical compounds (Beutler et al.,
2006): microbial products such as lipopolysaccharide and lipo-
teichoic acid and nucleic acids derived from pathogens, partic-
ularly viruses. Receptors involved in recognition of nucleic acids
from viruses activate IFN I secretion, which places the host in a
state of general alert (Stetson and Medzhitov, 2006). DCs ex-
press a variety of pattern recognition receptors (PRRs), such as
toll-like receptors (TLRs), retinoic-acid-inducible gene (RIG)-like
helicases (RLHs), or nucleotide-binding domain and leucine-rich
repeat-containing molecules (NLRs) (Akira et al., 2006). The
TLRs recognizing nucleic acids, namely TLR3 (sensing double-
stranded RNA [dsRNA]), TLR7 and TLR8 (sensing single-
stranded RNA [ssRNA]), and TLR9 (sensing CpG-DNA), are
located in endosomal compartments within the cytosol (Alexo-
poulou et al., 2001; Heil et al., 2004; Hemmi et al., 2000). TLRsImmunity 32, 279–289, February 26, 2010 ª2010 Elsevier Inc. 279
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Figure 1. FACS Separation of cDC Subsets and pDCs
(A) Enriched CD11chigh DCs were separated by flow cytometry into the three
cDC subsets, according to CD4 and CD8a expression.
(B) Enriched CD11cint DCs were separated by flow cytometry into pDCs, ac-
cording to CD45RA and Sirpa expression.
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Label-free Quantitative Proteomics of DC Subsetsin general elicit cellular responses by recruiting several adaptor
molecules, such as myeloid differentiation primary response
gene 88 (Myd88) and toll-like receptor adaptor molecule 1 (Ti-
cam1), leading to the expression of inflammatory genes (Kawai
and Akira, 2008). DC subsets differ in their ability to sense viral
infections. pDCs largely rely on the TLR system, namely TLR7
and TLR9, whereas cDCs mainly use the cytoplasmic virus
sensors RIG-I and melanoma differentiation antigen 5 (MDA5)
(Kato et al., 2005). Several studies using mice lacking RIG-I
and MDA5 reported the importance of both cytoplasmic sensors
for different virus infection models in vivo and in vitro (Kato et al.,
2006, 2008). RIG-I and MDA5 recruit adaptor molecules like
Mavs (also called Cardif, VISA, or IPS-1) (Meylan et al., 2005)
that are distinct from those that mediate TLR signaling, although
both pathways converge on IFN regulatory factors (IRFs) and
NF-kB for the production of inflammatory cytokines and IFNs
(Kawai and Akira, 2008).
The molecular basis for the functional segregation of cDC
subsets is still incompletely defined. We reasoned that differ-
ences in protein abundance might provide us with direct insights
into functional differences among cDC subsets.
Mass spectrometry (MS)-based proteomics can identify and
quantify thousands of proteins in complex samples (Aebersold
and Mann, 2003; Ong and Mann, 2005; Panchaud et al., 2008)
Most quantitative MS methods rely on differential labeling of
protein samples with stable isotopes. Our laboratory developed
stable isotope labeling with amino acids in cell culture (SILAC)
as a strategy that can accurately determine protein expression
ratios (Ong et al., 2002). We showed recently that the SILAC
approach can also be used to label entire mice (Kru¨ger et al.,
2008). Unfortunately, comparison of DC subsets in vivo would
require pooling of cells isolated from a large number of labeled
animals and, therefore, be prohibitively expensive. An alternative
to stable isotope labeling is ‘‘label-free’’ quantitation. In this
case, peptide intensities measured during individual liquid chro-
matography (LC) runs are compared across runs (Bantscheff
et al., 2007). Label-free quantitation is attractive because it can
be applied to any proteomic sample without the need of intro-
ducing isotopes for quantitation. However, label-free methods
are traditionally much less accurate than isotope-based meth-
ods, and proteome-wide quantitation has not yet been possible
(Schiess et al., 2009; Xu et al., 2008). Major challenges in label-
free quantitation are difficulties in the matching of thousands of
peptides across samples, variability in LC-MS resulting in reten-
tion time shifts, and errors introduced by slight differences in
sample fractionation steps.
Here, we studied the differences in abundance of proteins in
DC subsets using an algorithm for label-free quantitation, which
we have recently developed (J.C., C.A.L., N. Nagaraj, and M.M.,
unpublished data). We introduce this MS-based label-free quan-
titation approach to profile protein abundance differences of
cDC subsets to a depth of more than 5,000 proteins, requiring
only 1.5–2.0 3 106 purified cells. This technology now makes it
possible to study closely related cell types in vivo. Expression
profiles showed substantial overlap but also highly informative
differences in protein composition among the three cDC
subsets. Our analysis revealed mutually exclusive expression
of pattern recognition pathways not previously known to be
subset specific. We showed that members of the NLR, TLR,280 Immunity 32, 279–289, February 26, 2010 ª2010 Elsevier Inc.and RLH signaling pathways were differentially expressed in
cDC subsets. Among these, RIG-I and MDA5 were significantly
higher or uniquely expressed by CD4+ and DN cDCs (p %
0.01, standard t test). Only CD4+ and DN cDC subsets, by virtue
of their selective expression of RLH, were activated in response
to direct infection with certain ssRNA viruses and were able to
produce key antiviral cytokines, such as IFN-a. Although in-
fected, CD8a+ cDCs were not themselves activated and retained
their ability to cross-present in the presence of virus. Thus, label-
free, proteome-wide quantitation assigns and clarifies key viral
recognition functions to cDC subsets.
RESULTS
Quantitative Proteomic Comparison of DC Subsets
To identify differentially expressed proteins among spleen DC
subsets, we used a MS-based proteomics approach. The
cDCs were sorted into subsets by flow cytometry, according
to the expression of CD8a and CD4 surface molecules (Fig-
ure 1A). cDC preparations from pooled spleens of 32 mice
consistently yielded more than 2.5 3 106 cDCs per subset with
purity higher than 95% (data not shown). Spleen pDCs were
also sorted in separate experiments based on the expression
of CD11c, CD45RA, and Sirpa (Figure 1B). Sorted pDCs and
CD4+, CD8a+, and DN cDCs, resulting in 15 to 20 mg total protein
each, were separated by one dimensional (1D) SDS-PAGE and,
after tryptic in-gel digestion, analyzed by online LC-MS. We
repeated this experiment twice, with different pools of spleens
resulting in biological triplicates. MS data from all 126 gel slices
of the three independent large scale cDC subset experiments
were combined and analyzed by MaxQuant (Cox and Mann,
2008). We incorporated new algorithms for label-free
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Figure 2. Quantitative Differences between
cDC Subsets
(A–C) Volcano plot of protein expression differ-
ences between cDC subsets as a function of
statistical significance (standard t test p value %
0.01) as indicated for CD4+ (red), CD8a+ (green),
and DN (blue) cDCs. Proteins with no statistically
significant difference in expression between
subsets (p > 0.01) are in gray. Proteins with no
detectable signal in one of the subsets were as-
signed a ratio of infinity. Values are median fold
changes of three separate DC preparation and
MS experiments.
(D) Filled histograms show expression of CD97 by
cDC subsets as indicated. Unfilled histograms
show unstained background controls. Data is
representative of two experiments.
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Label-free Quantitative Proteomics of DC Subsetsquantitation into MaxQuant, which enabled us to quantify
peptides across individual MS runs (J.C., C.A.L., N. Nagaraj,
and M.M., unpublished data). Analysis of the entire cDC data
set using uniform statistical criteria identified 1,283,676 peptidesImmunity 32, 279–289,(99,228 nonredundant sequences), corre-
sponding to 5359, 5642, and 4830
proteins in CD4+, CD8a+, and DN cDCs
with 99% certainty, respectively.
Summed peptide intensity is a good
proxy for absolute protein abundance
(de Godoy et al., 2008), and by this
measure, we covered the cDC proteomes
across more than four orders of magni-
tude. The cDC proteome of 5,780
proteins shows no bias against low-level
regulatory proteins such as kinases (209
identified or 3.6% of our proteome versus
4.2% in the genome).
Relative label-free quantitation was
highly reproducible between biological
replicates and correlation between
normalized protein intensities was
between 0.84 and 0.96 (Figures S1A–
S1C). It thus provides an accurate means
of comparing differences in protein
expression between cDC subsets in vivo
for thousands of proteins (Table S1).
Expression of most proteins was similar,
and only a relatively small number
showed statistically significant and highly
reproducible differences between any
two subsets (standard t test p value %
0.01) (Figures 2A–2C and Figures S1D–
S1F). Overall, differences in protein
expression patterns showed that CD4+
and DN cDCs were more closely related
to each other than to CD8a+ cDCs
(judged by the median of the outliers,
Figures 2A–2C) as already suggested by
microarray analysis (Edwards et al.,
2003a).We then compared the label-free quantitation data with known
marker proteins of cDC subsets. All subsets expressed CD11c,
the pan-marker of DCs. Markers for other lymphocyte lineages,
such as CD19, CD3 subunits, or Nk1.1, were not detected,February 26, 2010 ª2010 Elsevier Inc. 281
Table 1. Expression of Known Marker Proteins Determined by
Mass Spectrometry
CD8a+ cDC CD4+ cDC DN cDC
CD11c 57,823,000 78,828,000 55,484,000
CD8a 3,876,600 0 0
CD205 6,461,300 381,840 443,580
CD36 3,421,300 92,491 445,720
Necl2 950,650 0 0
CD4 0 1,096,000 0
Sirpa 139,680 6,585,700 4,044,100
33D1 0 950,990 694,500
CD11b 1,211,600 17,304,000 16,806,000
Numbers are the median of summed peptide intensities in ion counts per
second over three biological replicates.
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Label-free Quantitative Proteomics of DC Subsetsindicating that sorted cDC populations were indeed pure. The
surface markers CD4 and CD8a were expressed by the respec-
tive population and correctly assigned by our bioinformatic
algorithms. Importantly, this was also true for other known
surface markers, such as DEC-205, CD36, and Necl2 for
CD8a+ cDCs and CD11b, 33D1, and SIRPa for CD4+ and DN
cDCs (Table 1). Clec9a was recently described as a C-type
lectin-like molecule with restricted expression on CD8a+ cDCs
in mice and a subset of human blood DCs (Caminschi et al.,
2008; Huysamen et al., 2008; Sancho et al., 2009). Thus, similarly
to Necl2 (Galibert et al., 2005), it may be useful to align human
and mouse cDC subsets. We detected two peptides of Clec9a
exclusively in CD8a+ cDCs (however, despite unambiguous
identification, we could not quantify this detectable Clec9a
expression as differentially significant because of its low signal
to noise). Correct assignment of these key surface markers by
hypothesis-free quantitative label-free proteomics demon-
strates the robustness of our approach. CD97 was 4-fold more
abundant in CD8a+ compared to CD4+ cDCs. Flow cytometry
with antibodies against CD97 independently confirmed our
proteomic finding (Figure 2D). Previous microarray data did not
classify CD97 as differentially expressed among cDCs (Dudziak
et al., 2007; Edwards et al., 2003a). Our data illustrates that
proteome and transcriptome measurements do not necessarily
agree, either due to technical factors or due to additional regula-
tion at the protein level (Bonaldi et al., 2008).
Mice that lack IFN regulatory factor 8 (IRF-8) essentially lack
CD8a+ cDCs and pDCs (Tamura et al., 2005), and we found
that this transcription factor was specifically expressed in
CD8a+ compared to CD4+ cDCs (Table S1). Mice that lack
IRF-4 (Tamura et al., 2005) and the NF-kB subunit RelB (Wu
et al., 1998) have reduced numbers of CD4+ and DN cDCs. In
concordance with this genetic finding, these transcription
factors were much more abundant in CD4+ cDCs (Table S1).
The NF-kB family members NfkB1 and NfkB2 have a similar
expression pattern to RelB, whereas RelA and c-Rel have no
subtype specificity, suggesting a functional specialization of
the NF-kB pathway in cDC subtypes. This was previously only
suggested by differential effects on DC subsets in mutant mice
lacking members of the NF-kB family (O’Keeffe et al., 2005;
Wu et al., 1998).282 Immunity 32, 279–289, February 26, 2010 ª2010 Elsevier Inc.Protein Expression Reflects Different Functionality
of cDC Subsets
PRRs endow DCs and other cells with the ability to sense PAMPs
(Akira et al., 2006). We reasoned that differences in protein abun-
dance of individual PRRs might provide us with direct insights
into functional differences between cDC subsets. It was previ-
ously known that certain TLRs are differentially expressed by
cDCs (TLR7 only in CD4+ and DN cDCs; TLR3 mainly in CD8a+
cDCs), and this was confirmed by our data (Table S1) (Edwards
et al., 2003b). Analysis of the expression of other TLRs identified
in our analysis revealed that the expression of two poorly charac-
terized members of the TLR family, TLR12 and TLR13, were
mainly restricted to CD8a+ cDCs. Conversely, members of the
NLRs, NOD1, and IPAF were much more highly expressed in
CD4+ and DN cDCs (Figure 3). CD8a+ cDCs are known to be
equipped with antiviral functions via their ability to present viral
antigens, including their unique ability to cross-present, their
ability to produce high amounts of IL-12, which activates antiviral
NK cells and T cells (Allan et al., 2003; Belz et al., 2004, 2005;
Maldonado-Lo´pez et al., 1999), and their high expression of
TLR3 and TLR9 (Table S1) (Edwards et al., 2003b). In contrast,
the CD4+ and DN cDC subsets have been associated with the
ability to induce Th2 cell responses and, besides their expres-
sion of TLR7 and -9, have not been shown to play a major role
in antiviral defense. Our data showed a higher expression of
the viral RNA recognition molecules RIG-I and MDA5 (Kato
et al., 2006, 2008) in CD4+ and DN DCs (Figure 3). These RLHs
signal through interaction with Mavs, which relays the signal to
downstream activation of transcription factors and IFN I
response and proinflammatory responses (Meylan et al., 2005).
Consistently, NLRX1, a potent regulator of Mavs, is also more
highly expressed in CD4+ cDCs (Figure 3; Table S1). RIG-I was
described to be essential for induction of IFN I upon RNA virus
infection of all cDCs (Kato et al., 2005). Our results now suggest
that not all cDC subsets are equally equipped to sense RNA
viruses. This is further supported by the higher expression in
CD4+ and DN cDCs of OAS1 and OAS3, which are 20,50-oligoade-
nylate synthetases (OAS) involved in antiviral defense (Silverman,
2007). The restriction of cytoplasmic viral recognition to CD4+
and DN cDCs does not appear to be limited to RNA viruses or
RNA intermediates because we also identified DAI (also known
as DLM1 or ZBP1), a cytosolic PRR activated by dsDNA (Ta-
kaoka et al., 2007), to be more abundant in CD4+ and DN
cDCs than in CD8a+ cDCs (Figure 3; Table S1).The Proteome of pDCs
Having established an in-depth proteome of cDCs, we also
wished to provide the proteome of the other main population
of DCs, the plasmacytoid DCs. In a triplicate series of experi-
ments, we separately determined the proteome of pDCs to a
depth of 6,664 proteins with 99% certainty (Table S2). Our
measurements between biological triplicate experiments were
highly reproducible (Figure S2). As expected, pDCs express
IRF-4, IRF-7, and IRF-8 (Table S2) (Tailor et al., 2006). PRRs de-
tected in the proteome of pDCs include TLR7 and TLR9 and, like
CD4+ and DN cDC subsets, this DC population also expressed
RIG-I and MDA5 (Table S2). In common with CD8a+ cDCs,
pDCs have TLR12 (Table S2). Thus, the pDCs show expression
Figure 3. Differential Expression of PRRs between CD4+ and CD8a+ Splenic cDCs
Members of PRR pathways are color-coded according to statistical significance (standard t test p value), with red denoting higher expression in CD4+ cDCs with
p% 0.01. Green denotes higher expression in CD8a+ cDCs with p% 0.01. Gray filled boxes designate proteins with no statistically significant change between
subsets (p > 0.01). Open boxes with an asterisk indicate proteins that have been detected but were not quantified. Remaining open boxes represent undetected
proteins. Numbers in parentheses are fold changes determined by label-free proteomics. Pathways are adapted from Hara et al. (2008), Ishikawa et al. (2009),
Kawai and Akira (2007), Komuro et al. (2008), Moore et al. (2008), Robinson et al. (2009), Saitoh and Miyake (2009), Silverman (2007); Tabeta et al. (2004), Takaoka
et al. (2007), and Yamamoto-Furusho et al. (2006).
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Label-free Quantitative Proteomics of DC Subsetsof both endosomal and cytoplasmic PRRs, overlapping with the
CD8a+, CD4+, and DN cDCs.
Differential Sensing of Virus Infection
among DC Subsets
We directly tested the hypothesis arising from our unbiased
quantitative proteomics experiment that cDC subsets differ in
their ability to sense viral infection. We challenged purified cDC
subsets with Sendai virus, a known activator of RIG-I (Kato
et al., 2006). The activation-specific marker CD86 was increased
in CD4+ and DN cDCs after viral infection, whereas CD8a+ cDCs
did not show any upregulation of CD86 (Figure 4A). We mea-
sured IFN-a production after viral infection and found that—
corresponding to cell surface maturation—only CD4+ cDCs
and DN cDCs produced IFN-a. The production of IL-6 and
IFN-b in response to Sendai virus was also restricted to CD4+
and DN cDC subsets (data not shown). Thus only CD4+ and
DN cDCs, but not CD8a+ cDCs, respond to direct Sendai
virus infection. Culture of cDC subsets with Sendai-GFP virus
revealed that all three subsets highly expressed GFP, demon-
strating they were similarly infected (Figures S3A–S3C).
It was possible that differences in virus detection depend on
differential TLR signaling rather than on differential expression
of RLHs. We ruled out this possibility using mice lacking
Myd88 (Adachi et al., 1998), an adaptor protein for most TLRsignaling pathways. After viral infection of cDCs from these
mice, both CD4+ and DN cDCs, but not CD8a+ cDCs, upregu-
lated CD86 and produced IFN-a, showing that responsiveness
to Sendai virus is functional in the absence of TLR signaling
(Figure 4B). To further verify that the RIG-I antiviral pathway is
indeed the unique feature enabling CD4+ and DN cDCs, but
not CD8a+ cDCs, to recognize direct viral infection, we tested
responses of DCs derived from Mavs/ mice (Michallet et al.,
2008). Without Mavs, none of the cDC subsets is expected to
recognize Sendai virus infection via RIG-I. Virus infection indeed
did not result in any detectable surface activation or IFN-a
production from any of the cDC subsets of Mavs/ mice (Fig-
ure 4C). In contrast, the production of IFN-a and other cytokines
by pDCs in response to different viruses was not affected in
Mavs/ mice (Figure S4).
Cultures of bone marrow (bm) with fms-like tyrosine kinase 3
ligand (FL) to generate FLDCs containing phenotypic and func-
tional equivalents of CD8a+ cDCs (eCD8+) and equivalents of
both CD4+ and DN cDCs (eCD8) (Naik et al., 2005) were also
prepared from WT, Myd88/, and Mavs/ mice. eCD8 DCs,
but not eCD8+ DCs of WT and Myd88/ mice, were still able
to produce IFN-a in response to Sendai virus, but this response
was completely abrogated in Mavs/ mice (Figure 4D). Thus, in
the bm model, Sendai virus recognition by eCD8 DCs is also
specifically dependent on the RLH pathway, but not on theImmunity 32, 279–289, February 26, 2010 ª2010 Elsevier Inc. 283
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Figure 4. Response of WT, Myd88/, and
Mavs/ DC Subsets to Sendai Virus Infec-
tion In Vitro
(A–C) Histograms showing expression of CD86
of sorted splenic cDC subsets of (A) WT, (B)
Myd88-, and (C) Mavs-deficient mice after incuba-
tion with Sendai virus (filled histograms) or without
stimulation (open histograms). Sorted splenic
cDC subsets of (A) WT, (B) Myd88- and (C) Mavs-
deficient mice, as indicated, were stimulated
with Sendai virus, and supernatants were analyzed
for IFN-a.
(D) Sorted spleen cDC equivalents of bone-
marrow-derived FLDCs from WT, Myd88-, and
Mavs-deficient mice were infected with Sendai
virus, and supernatants were analyzed for IFN-a
by ELISA. Representative results of at least three
experiments are shown. Data represent mean ±
SD. *not detected.
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Label-free Quantitative Proteomics of DC SubsetsTLR pathway. It should be noted that although the IFN-a
response of CD4+, DN cDCs, and eCD8 DCs in response to
Sendai virus was completely dependent upon Mavs, the
amounts of IFN-a produced by these cells from Myd88/
mice were less than 50% of WT amounts (Figure 4). This
suggests, as previously shown in fibroblasts and macrophages
(Rasmussen et al., 2009), that TLR and RLH may synergistically
cooperate in CD8 DC subsets to induce maximal cytokine
responses to viral infection.
Next, we wanted to demonstrate that the subset specific viral
recognition was not restricted to a particular virus and employed
another ssRNA virus, NS1-deleted mutant influenza A virus (Flu).
As with Sendai virus, CD8a+ cDCs were not responsive to Flu
virus, as demonstrated by a lack of IFN-a, IL-6, MIP-1a, and
MIP-1b production (Figure 5). Likewise, in concordance with
Sendai virus infection, CD4+ and DN cDCs produced these cyto-
kines in response to Flu virus, and this response was absolutely
dependent upon the RLH pathway, as demonstrated by its abro-
gation in Mavs/ mice (Figure 5).284 Immunity 32, 279–289, February 26, 2010 ª2010 Elsevier Inc.Collectively, these results demonstrate
that CD4+ and DN cDCs, in contrast to
CD8a+ cDCs, are uniquely equipped
with a functional RLH pathway to sense
viral infection with ssRNA viruses.
CD8a+ cDCs Are Functionally
Active in the Presence of Virus
The lack of CD8a+ cDC activation in
response to infection with either Sendai
or Flu virus could, in principle, be due to
rapid killing or inactivation by these
viruses. To exclude this possibility, we
infected CD8a+ cDCs with Sendai virus
in the presence of phosphorothioated
CpG-motif containing oligonucleotides
(CpG1668) and polyionosinic-polycyti-
dylic acid (poly I:C). This TLR9 and TLR3ligand combination is a stimulus known to induce high amounts
of cytokines from CD8a+ cDCs (Hochrein et al., 2001). The
production of IL-12p70, IL-6, TNF-a, MIP-1a, and MIP-1b by
the CD8a+ cDCs were not affected by the additional presence
of Sendai virus (Figure S5A). Of note, and in line with these obser-
vations, viral infection also did not enhance the production of any
of these cytokines.
The direct and cross-presentation capabilities of CD8a+ cDCs
are important in the course of viral infection (Allan et al., 2003). To
test whether the nonresponsiveness of CD8a+ cDCs to Sendai
virus was concomitant with an impaired ability to cross-present
antigen, we tested if CD8a+ cDCs could cross-present antigen in
the presence of Sendai virus. As shown in Figure S5B, the CD8a+
cDCs cross-presentation of ovalbumin (OVA) peptides derived
from OVA-coated spleen cells, to OT-I T cells, is still functional
in the presence of Sendai virus. The number of proliferating
OT-I T cells is reduced by about 20% but was still about ten
times greater than the proliferation induced by the other cDC
subsets.
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Figure 5. Cytokine Secretion of WT and
Mavs/ DC Subsets to Flu Virus Infection
In Vitro
Sorted splenic cDC subsets of WT and Mavs-defi-
cient mice, as indicated, were stimulated with Flu
virus, and supernatants were analyzed for IFN-a,
IL-6, MIP-1a, and MIP-1b. Representative results
of at least three experiments are shown. Data
represent mean ± SD. *not detected.
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to ssRNA viruses, such as Sendai and Flu virus, that require the
RLH pathway for recognition indicated that, indeed, these cells
are activated via the RLH pathway. CD8a+ cDCs, on the other
hand, do not express these molecules and, indeed, when infected
with either Sendai or Flu virus, were not activated. However, in
presence of these viruses, CD8a+ cDCs maintain the ability to
cross-present antigen and respond to TLR3 and TLR9 stimuli.DISCUSSION
Here, we showed that comprehensive MS-based proteomics,
combined with label-free quantitation algorithms, can determine
the differences in protein abundance for a substantial part of the
proteome of cDC subsets in vivo.Immunity 32, 279–289,To our knowledge, our data set is the
most comprehensive quantitative pro-
teome comparison of different in vivo
cell populations obtained so far. We
achieved reliable and reproducible quan-
titation for more than 5,000 proteins from
a few micrograms of rare cell types
directly isolated from mice. The approach
does not involve metabolic labeling and
can thus be used to quantify in vivo
protein levels in all organisms, including
humans. The approach was validated by
its ability to identify known subset-
specific markers. Subsetspecific proteins
were detected and validated, including
CD97, which was not classified as differ-
entially expressed by microarray studies
(Dudziak et al., 2007; Edwards et al.,
2003a). Our results demonstrate that
label-free quantitation can be used to
directly compare amounts of thousands
of proteins in vivo.
Previous functional and microarray
data demonstrated selective expression
of PRRs among cDC subsets. Our pro-
teomic analyses additionally revealed
that the orphan receptors TLR12 and
TLR13 were found to be more abundant
in CD8a+ cDCs. Thus, among cDCs, the
ligands of these TLR would only stimulate
CD8a+ cDCs. The pDC proteome also
reveals their expression of TLR12. Identi-fying TLR12 and -13 ligands may provide further insights into the
functional capacity of these DC subsets.
The cytosolic, inflammasome-associated NLRs are involved in
the activation of caspase-1 and the secretion of proinflammatory
cytokines, such as IL-1 and IL-18 (Kanneganti et al., 2007). We
found higher expression of the NLR-associated molecules
NOD1, IPAF, CARD9, and CARD11 in CD4+ and DN cDCs, sug-
gesting further functional separation among cDC subsets.
Finally, we show that RLHs, cytoplasmic RNA detectors, and
some key RLH signaling molecules are expressed more abun-
dantly or even exclusively in CD4+ and DN cDCs. Only these
cDC subsets produce IFN I and other cytokines and display an
activated surface phenotype upon infection with the ssRNA Sen-
dai or flu viruses. This viral recognition was specific for the RLH
pathway in these cDCs because it was functional in Myd88
mutant mice but abolished in mice lacking the essential RLHFebruary 26, 2010 ª2010 Elsevier Inc. 285
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stream signaling molecules, but the response of pDCs to either
Sendai or Flu virus was not affected in Mavs/ mice. Thus, in
line with previous studies (Kato et al., 2005), pDCs utilize mainly
TLR-dependent mechanisms for viral recognition. It has recently
been shown that pDCs utilize the RLH pathway in response to
viruses replicating in the cytoplasm in the absence of IFN I
receptor signaling (Kumagai et al., 2009). The expression of
RLHs and the downstream signaling molecules by pDCs appear
particularly important in response to viruses that may escape
TLR-dependent recognition. Unlike in macrophages (Imaizumi
et al., 2006), the high levels of RIG-I expressed by CD4+ and
DN cDC subsets of mouse spleen were constitutive and did
not require prior cell activation, suggesting that the mouse
CD4+ and DN cDCs are already ‘‘primed’’ for rapid cytoplasmic
virus recognition. This is analogous to the high expression of
TLR7 and TLR9 by pDCs, allowing rapid recognition of endoso-
mal pathogens. Thus, the CD4+ and DN cDCs are equipped as
‘‘professional’’ cytoplasmic virus sensors. Given the fact that
these subsets also preferentially express NLR, our data raise
the possibility that these cells are specialized for the rapid
response to cytoplasmic pathogens.
The RLHs are expressed nearly ubiquitously in hematopoietic
and nonimmune cells (Yoneyama and Fujita, 2009), so the
absence in CD8a+ cDCs may be important for the biology of
these cells. CD8a+ cDCs are well known for their cross-presen-
tation capacity. This capacity is abrogated within a short time
frame upon stimulation (Wilson et al., 2006). Lack of responsive-
ness to RNA and lack of, or at least delay in, CD8a+ cDC activa-
tion might be necessary for effective cross-priming in RNA virus
infections. Moreover, the RLH pathway has been implicated in
the recognition of DNA (Choi et al., 2009), possibly, at least in
the case of EBV, via RNA polymerase III (Ablasser et al., 2009).
We hypothesize that cross-presentation by CD8a+ cDCs and
direct presentation by virally infected CD8a+ cDCs and conse-
quent CTL priming is given a ‘‘head start’’ during viral infection
by avoiding the activation of CD8a+ cDCs by infecting virus.
The presence of infecting virus does not dramatically affect the
ability of CD8a+ cDCs to cross-present. Therefore, a non-acti-
vated CD8a+ cDC, even if itself is infected, would retain the
ability to present antigen during early infection. Activation of
CD8a+ cDCs would increase in an environment of viral-induced
cell death because the expression of receptors such as Clec9a
(Sancho et al., 2009), equipping CD8a+ cDCs for the uptake of
dying cells, allows the subsequent transport of the viral-loaded
dead cell cargo to the endosomes containing TLR3 and TLR9.
As an interesting consequence of the lack of RLHs, CD8a+
cDCs, or their immediate precursors (Bedoui et al., 2009) could
potentially be manipulated by certain siRNAs without activating
these cells. Specifically, short hairpin RNAs (shRNAs) activate
cells via RIG-I and not via TLR3 (Kenworthy et al., 2009), making
shRNA an attractive tool for selective ablation of genes of
interest in CD8a+ cDCs.
In conclusion, our study demonstrates the feasibility of quan-
tifying rare in vivo cell subpopulations at the protein level. The
proteomic expression data provided immediate insights into
the functional segregation of DC subsets. Direct infection of
DC subsets ex vivo using Sendai or Flu virus confirmed our
findings. The data produced in this study will provide extensive286 Immunity 32, 279–289, February 26, 2010 ª2010 Elsevier Inc.information for future detailed comparison of the proteomes of
mouse cDC subsets with human cDC subsets. Such a compar-
ison would be a powerful means for dissecting similarities and
differences between the DCs across species.
EXPERIMENTAL PROCEDURES
Mice
All mice were bred and maintained either in the animal facility at Bavarian
Nordic GmbH or the Max Planck Institute of Biochemistry (MPIB), according
to institutional guidelines. Experiments were generally done between 8–12
weeks of age. Mice lacking Myd88 were generated by S. Akira (Adachi
et al., 1998) and backcrossed on a C57BL/6 background by H. Wagner.
Mavs-deficient mice on a C57BL/6 background were provided by J. Tschopp
(Meylan et al., 2005). b2M-deficient mice and transgenic OT-I mice were
obtained from M. Suter (University of Zurich). C57BL/6 mice were provided
from the animal facility of MPIB.
Cells, Flow Cytometric Analysis, and Sorting
DC subsets were isolated from mouse spleens from Myd88/, Mavs/, and
C57BL/6 mice, as described (Vremec et al., 2007). cDC populations were
segregated from pre-enriched DC preparations based on the expression of
CD11c, CD45RA, CD4, and CD8a; pDCs were purified based on CD11c,
CD45RA, and Sirpa (all BD Biosciences) expression. Cell sorting was per-
formed on a FACS Aria instrument (BD Biosciences).
Activation of DC subsets was determined by CD86 expression using a FACS
Calibur instrument (BD Biosciences). Analysis of FACS data was performed
with WEASEL software (WEHI).
FLDCs were prepared as described (Naik et al., 2005). Recombinant murine
FL was expressed in Chinese hamster ovary cells and purified in house as
described previously (O’Keeffe et al., 2002). Fluorescent cell sorting into
both eCD8+ and eCD8-DC subsets was done based on expression of
CD11c, CD11b, CD24, CD103, and CD45R (all BD Biosciences).
Sample Preparation for MS
FACS-purified DC subsets were washed in PBS and immediately frozen on dry
ice. Lysates were boiled in 23 sample buffer (NuPAGE, Invitrogen) and sepa-
rated by 1D-SDS PAGE (4%–12% Bis-Tris Mini-Gel, Invitrogen). After Colloidal
Blue Staining (Invitrogen), gel pieces were excised from the gel and subjected
to reduction, alkylation and in-gel digestion with sequence grade modified
trypsin (Promega) as described (Shevchenko et al., 1996). After digestion,
peptides were extracted by 30% acetonitrile in 3% TFA in water, reduced in
a speedvac, and desalted using StageTips before analysis by MS (Rappsilber
et al., 2003).
MS Analysis of cDC Subsets
MS experiments of cDCs were performed on a nanoflow HPLC system (Agilent
Technologies 1100 or 1200) connected to a hybrid LTQ-Orbitrap (Thermo
Fisher Scientific), equipped with a nanoelectrospray ion source (Proxeon
Biosystems). Peptide mixtures were separated by reverse phase chromatog-
raphy using in-house-made C18 microcolumns (75 mm ID packed with Repro-
Sil-Pur C18-AQ 3 mm resin, Dr. Maisch GmbH) with a 2H gradient from 5% to
60% acetonitrile in 0.5% acetic acid at a flow rate of 200 nl/min and directly
electrosprayed into the mass spectrometer. The LTQ-Orbitrap was operated
in the data dependent mode to simultaneously measure full scan MS spectra
in the Orbitrap and the five most intense ions in the LTQ part by collisionally
induced dissociation, respectively.
MS Analysis of pDCs
Peptide mixtures of pDCs were separated by reverse phase chromatography
using in house-made C18 microcolumns (75mm ID packed with ReproSil-Pur
C18-AQ 3 mm resin, Dr. Maisch, GmbH) in a 2.5H gradient from 5% to 60%
acetonitrile in 0.5% acetic acid at a flow rate of 200 nl/min using a Proxeon
easy-nLC (Proxeon Biosystems), which was directly connected to a LTQ-
Orbitrap VELOS mass spectrometer (Thermo Fisher Scientific) via a nanoelec-
trospray ion source (Proxeon Biosystems). The LTQ-Orbitrap VELOS was
operated in the data-dependent mode to simultaneously measure full scan
Immunity
Label-free Quantitative Proteomics of DC SubsetsMS spectra in the Orbitrap and the ten most intense ions in the LTQ part by
collisionally induced dissociation, respectively. Background ions were
reduced by using an ABIRD device (ESI Source Solutions).
Data Processing and Analysis
The data analysis was performed with MaxQuant software, supported by
Mascot as a database search engine for peptide identification (mouse data-
base IPI 3.46) as described (Cox and Mann, 2008). Label-free quantitation
algorithms were added to MaxQuant by extracting isotope patterns for each
peptide in each run (J.C., C.A.L., N. Nagaraj, and M.M., unpublished data).
These isotope patterns were matched to each other across runs using peptide
identifications, very high mass accuracy, and nonlinearly remapped retention
time. Total peptide signals within each run were normalized in order to make
experiments comparable that were performed months apart. For label-free
quantitation, we compared the maximum number of peptides between any
two samples, resulting in a matrix of protein ratios, calculated as the median
of all ratios for common peptides. We used least-squares regression to solve
the overdetermined system of equations to obtain the best estimate for the
protein ratios. Details of the algorithm will be described elsewhere (J.C.,
C.A.L., N. Nagaraj, and M.M., unpublished data). The proportion of kinases
in the proteome and genome were determined using the gene ontology (GO)
term 0004672.
Virus Infection
Purified Sendai virus (Cantell strain, Charles River Laboratories) and delNS1
Influenza A virus (A/PR/8/34, H1N1, AVIR Green Hills Biotechnology) were
used for in vitro infection of sorted DC subsets from C57BL/6, Myd88/
and Mavs/ mice. 1 3 106 DCs per ml were infected with virus in RPMI
1640 medium supplemented with 10% FCS and antibiotics in the presence
of IL-3 and GM-CSF. Supernatants were harvested after 18 hr and IFN-a,
IFN-b, IL-6, TNF-a, MIP-1a, and MIP-1b were measured by ELISA as
described (Hochrein et al., 2004) or by flow cytometric bead assay (FlowCyto-
mix Simplex, Bender Medsystems) according to manufacturer’s protocol.
In Vitro Cross-presentation Assay
In vitro cross-presentation assay was performed as described (Schnorrer
et al., 2006) with slight modifications. In short, we incubated ex vivo sorted
spleen DC (1.5 3 104 cells/well) with 5 3 104 irradiated OVA-coated spleen
cells (OCS) from b2M-deficient mice and 5 3 10
4 CFSE-labeled OT-1 Ly5.1
cells in the presence of a known number of Calibrite beads (Becton Dickinson)
in complete medium containing 10 ng/ml GM-CSF. 500 nM CpG1668 and
Sendai virus were added as indicated. T cell proliferation was analyzed after
58 hr by FACS (gated on live CD8+ CD45.1+ CFSElo cells).
Data and Software Access Notes
Raw data and supplemental tables were uploaded to the Tranche database
(http://www.proteomecommons.org) and can be downloaded freely from the
website. Source code for label-free algorithms incorporated into MaxQuant
are available at the MaxQuant.org website upon publication.
SUPPLEMENTAL INFORMATION
The Supplemental Information include five figures and three tables and can be
found with this article online at doi:10.1016/j.immuni.2010.01.013.
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